80 FR 17442 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 80, Issue 62 (April 1, 2015)

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http:// beta.samhsa.gov/workplace.

[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)]
[Notices]
[Pages 17442-17444]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-07423]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines). The Mandatory Guidelines were first published 
in the Federal Register on April 11, 1988 (53 FR 11970), and 
subsequently revised in the Federal Register on June 9, 1994 (59 FR 
29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); 
November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and 
on April 30, 2010 (75 FR 22809).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the Internet at http://beta.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace 
Programs, SAMHSA/CSAP, Room 7-1051, One Choke Cherry Road, Rockville, 
Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).

SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially 
developed in accordance with Executive Order 12564 and section 503 of 
Pub. L. 100-71. The ``Mandatory Guidelines for Federal Workplace Drug 
Testing Programs,'' as amended in the revisions listed above, requires 
strict standards that laboratories and IITFs must meet in order to 
conduct drug and specimen validity tests on urine specimens for federal 
agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must 
have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), 
which attests that it has met minimum standards.
    In accordance with the Mandatory Guidelines dated November 25, 2008 
(73 FR 71858), the following HHS-

[[Page 17443]]

certified laboratories and IITFs meet the minimum standards to conduct 
drug and specimen validity tests on urine specimens:

HHS-Certified Instrumented Initial Testing Facilities:
    Gamma-Dynacare Medical Laboratories
    6628 50th Street NW.
    Edmonton, AB Canada T6B 2N7
    780-784-1190

HHS-Certified Laboratories:
    ACM Medical Laboratory, Inc.
    160 Elmgrove Park
    Rochester, NY 14624
    585-429-2264

    Aegis Analytical Laboratories, Inc.
    345 Hill Ave.
    Nashville, TN 37210
    615-255-2400
    (Formerly: Aegis Sciences Corporation, Aegis Analytical 
Laboratories, Inc., Aegis Analytical Laboratories)

    Alere Toxicology Services
    1111 Newton St.
    Gretna, LA 70053
    504-361-8989/800-433-3823
    (Formerly: Kroll Laboratory Specialists, Inc., Laboratory 
Specialists, Inc.)

    Alere Toxicology Services
    450 Southlake Blvd.
    Richmond, VA 23236
    804-378-9130
    (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing 
Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.)

    Baptist Medical Center-Toxicology Laboratory
    11401 I-30
    Little Rock, AR 72209-7056
    501-202-2783
    (Formerly: Forensic Toxicology Laboratory Baptist Medical Center)

    Clinical Reference Lab
    8433 Quivira Road
    Lenexa, KS 66215-2802
    800-445-6917
    DrugScan, Inc.
    200 Precision Road, Suite 200
    Horsham, PA 19044
    800-235-4890

    ElSohly Laboratories, Inc.
    5 Industrial Park Drive
    Oxford, MS 38655
    662-236-2609

    Fortes Laboratories, Inc.
    25749 SW Canyon Creek Road, Suite 600
    Wilsonville, OR 97070
    503-486-1023

    Gamma-Dynacare Medical Laboratories*
    A Division of the Gamma-Dynacare Laboratory Partnership
    245 Pall Mall Street
    London, ONT, Canada N6A 1P4
    519-679-1630

    Laboratory Corporation of America Holdings
    7207 N. Gessner Road
    Houston, TX 77040
    713-856-8288/800-800-2387

    Laboratory Corporation of America Holdings
    69 First Ave.
    Raritan, NJ 08869
    908-526-2400/800-437-4986
    (Formerly: Roche Biomedical Laboratories, Inc.)

    Laboratory Corporation of America Holdings
    1904 Alexander Drive
    Research Triangle Park, NC 27709
    919-572-6900/800-833-3984
    (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem 
Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche 
Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of 
the Roche Group)

    Laboratory Corporation of America Holdings
    1120 Main Street
    Southaven, MS 38671
    866-827-8042/800-233-6339
    (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/
National Laboratory Center)

    LabOne, Inc. d/b/a Quest Diagnostics
    10101 Renner Blvd.
    Lenexa, KS 66219
    913-888-3927/800-873-8845
    (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for 
Laboratory Services, a Division of LabOne, Inc.)

    MedTox Laboratories, Inc.
    402 W. County Road D
    St. Paul, MN 55112
    651-636-7466/800-832-3244

    MetroLab-Legacy Laboratory Services
    1225 NE 2nd Ave.
    Portland, OR 97232
    503-413-5295/800-950-5295

    Minneapolis Veterans Affairs Medical Center
    Forensic Toxicology Laboratory
    1 Veterans Drive
    Minneapolis, MN 55417
    612-725-2088

    National Toxicology Laboratories, Inc.
    1100 California Ave.
    Bakersfield, CA 93304
    661-322-4250/800-350-3515

    One Source Toxicology Laboratory, Inc.
    1213 Genoa-Red Bluff
    Pasadena, TX 77504
    888-747-3774
    (Formerly: University of Texas Medical Branch, Clinical Chemistry 
Division; UTMB Pathology-Toxicology Laboratory)

    Pacific Toxicology Laboratories
    9348 DeSoto Ave.
    Chatsworth, CA 91311
    800-328-6942
    (Formerly: Centinela Hospital Airport Toxicology Laboratory)

    Pathology Associates Medical Laboratories
    110 West Cliff Dr.
    Spokane, WA 99204
    509-755-8991/800-541-7891x7

    Phamatech, Inc.
    15175 Innovation Drive
    San Diego, CA 92128
    888-635-5840

    Quest Diagnostics Incorporated
    1777 Montreal Circle
    Tucker, GA 30084
    800-729-6432
    (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline 
Bio-Science Laboratories)

    Quest Diagnostics Incorporated
    400 Egypt Road
    Norristown, PA 19403
    610-631-4600/877-642-2216
    (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline 
Bio-Science Laboratories)

    Quest Diagnostics Incorporated
    8401 Fallbrook Ave.
    West Hills, CA 91304
    818-737-6370
    (Formerly: SmithKline Beecham Clinical Laboratories)

    Redwood Toxicology Laboratory
    3700650 Westwind Blvd.
    Santa Rosa, CA 95403
    800-255-2159

    Southwest Laboratories
    4625 E. Cotton Center Boulevard
    Suite 177
    Phoenix, AZ 85040
    602-438-8507/800-279-0027

    STERLING Reference Laboratories
    2617 East L Street
    Tacoma, Washington 98421
    800-442-0438

    U.S. Army Forensic Toxicology Drug Testing Laboratory
    2490 Wilson St.
    Fort George G. Meade, MD 20755-5235
    301-677-7085

    * The Standards Council of Canada (SCC) voted to end its Laboratory 
Accreditation Program for Substance Abuse (LAPSA) effective May 12, 
1998. Laboratories certified through that program were accredited to 
conduct forensic urine drug testing as required by U.S. Department of 
Transportation (DOT) regulations. As of that date, the

[[Page 17444]]

certification of those accredited Canadian laboratories will continue 
under DOT authority. The responsibility for conducting quarterly 
performance testing plus periodic on-site inspections of those LAPSA-
accredited laboratories was transferred to the U.S. HHS, with the HHS' 
NLCP contractor continuing to have an active role in the performance 
testing and laboratory inspection processes. Other Canadian 
laboratories wishing to be considered for the NLCP may apply directly 
to the NLCP contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 16, 
1996) as meeting the minimum standards of the Mandatory Guidelines 
published in the Federal Register on April 30, 2010 (75 FR 22809). 
After receiving DOT certification, the laboratory will be included in 
the monthly list of HHS-certified laboratories and participate in the 
NLCP certification maintenance program.

Janine Denis Cook,
Chemist Division of Workplace Programs, Center for Substance Abuse 
Prevention, SAMHSA.
[FR Doc. 2015-07423 Filed 3-31-15; 8:45 am]
BILLING CODE 4162-20-P